Evidence map›Paper›PMID 12210106›Full record

ArticleJournal of neurobiology2002

Presynaptic adenosine A1 receptors regulate retinohypothalamic neurotransmission in the hamster suprachiasmatic nucleus.

Richard Hallworth, Matthew Cato, Costa Colbert, Michael A Rea

Open access · greenAbstract read
In one paragraph

Article in Journal of neurobiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Systematic review of drugs that modify the circadian system's phase-shifting responses to light exposure.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  2. Review
  3. Review
  4. Article
  5. How Psychoactive Drugs and the Circadian Clock Are Enlightening One Another.Advances in experimental medicine and biology · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Sleep Deprivation and Caffeine Treatment Potentiate Photic Resetting of the Master Circadian Clock in a Diurnal Rodent.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  10. Review
  11. Article
  12. Adenosinergic regulation of striatal clock gene expression and ethanol intake during constant light.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  13. Potentiation of inhibitory synaptic transmission by extracellular ATP in rat suprachiasmatic nuclei.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  14. Article
  15. Purinergic regulation of hypothalamopituitary functions.Trends in endocrinology and metabolism: TEM · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Richard HallworthDepartment of Otolaryngology - Head and Neck Surgery, University of Texas Health Science Center at San Antonio, 78229-3900, USA.
Matthew Cato
Costa Colbert
Michael A Rea
University of Houston · US

Funding

Neurochemical Regulation of Circadian TimingR01MH062490 · NIMH · UNIVERSITY OF HOUSTON · PI REA, MICHAEL A. · 2001 to 2005
$1.3M
THE MECHANISM OF OUTER HAIR CELL MOTILITYR01DC002053 · NIDCD · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI HALLWORTH, RICHARD JOHN · 2000 to 2004
$1.0M
CELLULAR MECHANISMS OF INFORMATION PROCESSING IN NEURONSR29NS036982 · NINDS · UNIVERSITY OF HOUSTON · PI COLBERT, COSTA M · 1998 to 2002
$311k
NIDCD NIH HHS R01 DC002053NIMH NIH HHS MH62490NIMH NIH HHS R01 MH062490NINDS NIH HHS NS36982
6 · The paper itself

Abstract

Adenosine has been implicated as a modulator of retinohypothalamic neurotransmission in the suprachiasmatic nucleus (SCN), the seat of the light-entrainable circadian clock in mammals. Intracellular recordings were made from SCN neurons in slices of hamster hypothalamus using the in situ whole-cell patch clamp method. A monosynaptic, glutamatergic, excitatory postsynaptic current (EPSC) was evoked by stimulation of the optic nerve. The EPSC was blocked by bath application of the adenosine A(1) receptor agonist cyclohexyladenosine (CHA) in a dose-dependent manner with a half-maximal concentration of 1.7 microM. The block of EPSC amplitude by CHA was antagonized by concurrent application of the adenosine A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). The adenosine A(2A) receptor agonist CGS21680 was ineffective in attenuating the EPSC at concentrations up to 50 microM. Trains of four consecutive stimuli at 25 ms intervals usually depressed the EPSC amplitude. However, after application of CHA, consecutive responses displayed facilitation of EPSC amplitude. The induction of facilitation by CHA suggested a presynaptic mechanism of action. After application of CHA, the frequency of spontaneous EPSCs declined substantially, while their amplitude distribution was unchanged or slightly reduced, again suggesting a mainly presynaptic site of action for CHA. Application of glutamate by brief pressure ejection evoked a long-lasting inward current that was unaffected by CHA at concentrations sufficient to reduce the evoked EPSC amplitude substantially (1 to 5 microM), suggesting that postsynaptic glutamate receptor-gated currents were unaffected by the drug. Taken together, these observations indicate that CHA inhibits optic nerve-evoked EPSCs in SCN neurons by a predominantly presynaptic mechanism.

Indexed as

AdenosineAnimalsAntihypertensive AgentsCircadian RhythmCricetinaeExcitatory Postsynaptic PotentialsMaleMesocricetusNeural InhibitionPhenethylaminesPurinergic P1 Receptor AgonistsPurinergic P1 Receptor AntagonistsReceptors, PresynapticReceptors, Purinergic P1RetinaSuprachiasmatic Nucleus1,3-dipropyl-8-cyclopentylxanthine2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAntihypertensive AgentsN(6)-cyclohexyladenosinePhenethylaminesPurinergic P1 Receptor AgonistsPurinergic P1 Receptor AntagonistsReceptors, PresynapticReceptors, Purinergic P1Xanthines

Identifiers

PMID12210106
PMCPMC2104795
OpenAlexW1968161522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.